USA - New York Stock Exchange - NYSE:ARE - US0152711091 - REIT
The current stock price of ARE is 52.38 USD. In the past month the price increased by 15.17%. In the past year, price decreased by -44.86%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL | WELLTOWER INC | 128.04 | 127.42B | ||
| VTR | VENTAS INC | 146.42 | 35.77B | ||
| OHI | OMEGA HEALTHCARE INVESTORS | 23.86 | 13.12B | ||
| DOC | HEALTHPEAK PROPERTIES INC | 82.5 | 11.47B | ||
| AHR | AMERICAN HEALTHCARE REIT INC | 181.27 | 8.84B | ||
| CTRE | CARETRUST REIT INC | 26.76 | 8.19B | ||
| HR | HEALTHCARE REALTY TRUST INC | N/A | 6.04B | ||
| SBRA | SABRA HEALTH CARE REIT INC | 27.04 | 4.85B | ||
| DHCNL | DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 | N/A | 4.34B | ||
| DHCNI | DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 | N/A | 4.06B | ||
| NHI | NATL HEALTH INVESTORS INC | 25.2 | 3.64B | ||
| MPW | MEDICAL PROPERTIES TRUST INC | N/A | 3.19B |
Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 552 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.
ALEXANDRIA REAL ESTATE EQUIT
26 North Euclid Avenue
Pasadena CALIFORNIA 91101 US
CEO: Stephen A. Richardson
Employees: 552
Phone: 16265780777
Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 552 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.
The current stock price of ARE is 52.38 USD. The price increased by 5.73% in the last trading session.
ALEXANDRIA REAL ESTATE EQUIT (ARE) has a dividend yield of 5.88%. The yearly dividend amount is currently 5.22.
ARE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
ARE stock is listed on the New York Stock Exchange exchange.
19 analysts have analysed ARE and the average price target is 65.75 USD. This implies a price increase of 25.53% is expected in the next year compared to the current price of 52.38.
The outstanding short interest for ALEXANDRIA REAL ESTATE EQUIT (ARE) is 4.06% of its float.
ChartMill assigns a technical rating of 1 / 10 to ARE. When comparing the yearly performance of all stocks, ARE is a bad performer in the overall market: 91.87% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to ARE. ARE has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months ARE reported a non-GAAP Earnings per Share(EPS) of -2.47. The EPS decreased by -250.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.13% | ||
| ROE | -2.53% | ||
| Debt/Equity | 0.82 |
19 analysts have analysed ARE and the average price target is 65.75 USD. This implies a price increase of 25.53% is expected in the next year compared to the current price of 52.38.
For the next year, analysts expect an EPS growth of -178.13% and a revenue growth -3.45% for ARE